Outlook Therapeutics (OTLK) Net Cash Flow (2015 - 2026)
Outlook Therapeutics (OTLK) posted Net Cash Flow of $5.59 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 316.1% from $1.34 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Net Cash Flow (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Cash Flow at Outlook Therapeutics was $4.44 million; for FY2025 (ended Sep 30, 2025), it was -$6.84 million.
- In prior fiscal years, Outlook Therapeutics' Net Cash Flow was -$8.46 million in FY2024, $6 million in FY2023 (+105.4%), $2.92 million in FY2022 (+50.4%) and $1.94 million in FY2021 (-57.1%).
- The fiscal Q3 2026 figure stands as the highest quarterly Net Cash Flow since fiscal Q2 2024.
- According to Business Quant data, Net Cash Flow for the three prior fiscal quarters was -$929,198 (Q2 2026), $594,339 (Q1 2026) and -$817,729 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.27 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -722.00 Mn |
| 10 | Outlook Therapeutics | 80.68 Mn | 44.93 Mn | -8,265.00 | 5.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.59 Mn |
| Mar 31, 2026 | -929,198.00 |
| Dec 31, 2025 | 594,339.00 |
| Sep 30, 2025 | -817,729.00 |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | -9.22 Mn |
| Sep 30, 2024 | -17.10 Mn |
| Jun 30, 2024 | -15.20 Mn |
| Mar 31, 2024 | 36.87 Mn |
| Dec 31, 2023 | -13.04 Mn |
| Sep 30, 2023 | -10.32 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.71 Mn |
| Dec 31, 2022 | 34.94 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -32.40 Mn |
| Mar 31, 2022 | -11.73 Mn |
| Dec 31, 2021 | 55.67 Mn |
| Sep 30, 2021 | -5.21 Mn |
API Access
Outlook Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();